Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review47
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma42
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study36
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report30
Molecular basis of heterogeneity in small cell lung cancer28
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn25
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study23
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer23
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases23
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial21
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study20
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer20
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors19
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma19
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients18
Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study18
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer18
Combining Bulk RNA-seq and scRNA-seq data to identify RNA m5C methyltransferases NSUN1: a rising star as a biomarker for cancer diagnosis, prognosis and therapy18
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes18
0.21737384796143